Axcella Health Inc (AXLA)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-03-03 | 2023-03-01 | PS Planned sale |
Chief Medical Officer Officer |
679
-2.7%
0.58USD 394 |
679 -2.7% | 0.58 | USD 394 | |
| 2022-10-19 | 2022-10-19 | S Sale |
President & CEO Executive Director |
16,000
-16.3%
1.56USD 25,027 |
16,000 -16.3% | 1.56 | USD 25,027 | |
| 2022-10-17 | 2022-10-13 | B Purchase |
Societe des Produits Nestle S.A. Large shareholder |
3,658,536
+49.1%
1.64USD 5,999,999 |
3,658,536 +49.1% | 1.64 | USD 5,999,999 | |
| 2022-10-17 | 2022-10-13 | B Purchase |
Flagship Ventures Fund IV General Partner LLC Large shareholder |
3,048,780
+inf%
1.64USD 4,999,999 |
3,048,780 +inf% | 1.64 | USD 4,999,999 | |
| 2022-10-17 | 2022-10-13 | B Purchase |
Flagship Ventures Fund IV General Partner LLC Large shareholder |
919,111
+17.1%
1.64USD 1,507,342 |
919,111 +17.1% | 1.64 | USD 1,507,342 | |
| 2022-10-17 | 2022-10-13 | B Purchase |
Flagship Ventures Fund IV General Partner LLC Large shareholder |
914,634
+20.5%
1.64USD 1,500,000 |
914,634 +20.5% | 1.64 | USD 1,500,000 | |
| 2022-10-17 | 2022-10-13 | B Purchase |
Flagship Ventures Fund IV General Partner LLC Large shareholder |
2,757,333
+24.3%
1.64USD 4,522,026 |
2,757,333 +24.3% | 1.64 | USD 4,522,026 | |
| 2022-10-17 | 2022-10-13 | B Purchase |
Flagship Ventures Fund IV General Partner LLC Large shareholder |
2,743,902
+31.9%
1.64USD 4,499,999 |
2,743,902 +31.9% | 1.64 | USD 4,499,999 | |
| 2022-09-08 | 2022-09-06 | S Sale |
Chief Medical Officer Officer |
547
-2.1%
2.52USD 1,378 |
547 -2.1% | 2.52 | USD 1,378 | |
| 2022-06-02 | 2022-06-01 | S Sale |
Chief Medical Officer Officer |
590
-2.2%
2.01USD 1,186 |
590 -2.2% | 2.01 | USD 1,186 | |
| 2022-03-18 | 2022-03-16 | B Purchase | Non-Executive Director |
26,178
+19.4%
1.91USD 50,000 |
26,178 +19.4% | 1.91 | USD 50,000 | |
| 2022-03-18 | 2022-03-16 | B Purchase |
Flagship Ventures Fund IV General Partner LLC Large shareholder |
1,579,843
+54.7%
1.91USD 3,017,500 |
1,579,843 +54.7% | 1.91 | USD 3,017,500 | |
| 2022-03-18 | 2022-03-16 | B Purchase |
Flagship Ventures Fund IV General Partner LLC Large shareholder |
947,905
+89.7%
1.91USD 1,810,499 |
947,905 +89.7% | 1.91 | USD 1,810,499 | |
| 2022-03-18 | 2022-03-16 | B Purchase |
Flagship Ventures Fund IV General Partner LLC Large shareholder |
3,791,623
+78.8%
1.91USD 7,242,000 |
3,791,623 +78.8% | 1.91 | USD 7,242,000 | |
| 2022-03-18 | 2022-03-16 | B Purchase |
SVP & Chief Legal Officer Officer |
10,471
+101.4%
1.91USD 20,000 |
10,471 +101.4% | 1.91 | USD 20,000 | |
| 2022-03-18 | 2022-03-16 | B Purchase |
Chief Financial Officer Officer |
39,267
+inf%
1.91USD 75,000 |
39,267 +inf% | 1.91 | USD 75,000 | |
| 2022-03-18 | 2022-03-16 | B Purchase |
President & CEO Executive Director |
13,089
+37.5%
1.91USD 25,000 |
13,089 +37.5% | 1.91 | USD 25,000 | |
| 2022-03-16 | 2022-03-16 | B Purchase |
Societe des Produits Nestle S.A. Large shareholder |
3,141,361
+73.0%
1.91USD 6,000,000 |
3,141,361 +73.0% | 1.91 | USD 6,000,000 | |
| 2022-03-03 | 2022-03-01 | S Sale |
Chief Medical Officer Officer |
553
-2.0%
1.86USD 1,030 |
553 -2.0% | 1.86 | USD 1,030 | |
| 2022-02-01 | 2022-01-31 | S Sale |
President and CEO Executive Director |
16,590
-33.2%
1.65USD 27,393 |
16,590 -33.2% | 1.65 | USD 27,393 |